In this study, we showed that full-length eIF4A1 and eIF4A2, sharing exactly 95.3% similarity in amino acid sequences (see Supplementary Figure S5), exhibit different enzymatic properties, which may result in their distinct roles in cancer development. The gene discussed is EIF4A1; the disease is cancer.